On the public citation graph

Small cell carcinoma of the prostate after high-dose-rate brachytherapy for low-risk prostatic adenocarcinoma

0 signed · 31 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1001/jama.280.11.969openalex-snapshot
Biochemical Outcome After Radical Prostatectomy, External Beam Radiation Therapy, or Interstitial Radiation Therapy for Clinically Localized Prostate Cancer
inferredcites →https://doi.org/10.1002/(sici)1097-0045(1998)8+<43::aid-pros8>3.0.co;2-hopenalex-snapshot
Evaluation and clinical value of neuroendocrine differentiation in human prostatic tumors
inferredcites →https://doi.org/10.1002/1097-0142(19870515)59:10<1803::aid-cncr2820591019>3.0.co;2-xopenalex-snapshot
Small cell carcinoma of the prostate part I a clinicopathologic study of 20 cases
inferredcites →https://doi.org/10.1002/1097-0142(19920701)70:1+<254::aid-cncr2820701312>3.0.co;2-eopenalex-snapshot
Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implications
inferredcites →https://doi.org/10.1002/pros.20910openalex-snapshot
Shared TP53 gene mutation in morphologically and phenotypically distinct concurrent primary small cell neuroendocrine carcinoma and adenocarcinoma of the prostate
inferredcites →https://doi.org/10.1007/s004280050357openalex-snapshot
Undifferentiated carcinoma of the prostate with small cell features: immunohistochemical subtyping and reflections on histogenesis
inferredcites →https://doi.org/10.1016/j.eururo.2005.03.017openalex-snapshot
Changes in Chromogranin A Serum Levels During Endocrine Therapy in Metastatic Prostate Cancer Patients
inferredcites →https://doi.org/10.1016/j.mpdhp.2008.02.005openalex-snapshot
Small cell carcinoma of the prostate
inferredcites →https://doi.org/10.1016/s0022-5347(17)37390-1openalex-snapshot
Small Cell Anaplastic Carcinoma of the Prostate: A Clinical, Pathological and Immunohistological Study of 27 Patients
inferredcites →https://doi.org/10.1016/s0022-5347(17)37427-xopenalex-snapshot
Chemotherapy for Small Cell Carcinoma of Prostatic Origin
inferredcites →https://doi.org/10.1016/s0302-2838(03)00257-4openalex-snapshot
Neuroendocrine Serum Tumour Markers in Hormone-Resistant Prostate Cancer
inferredcites →https://doi.org/10.1016/s0344-0338(87)80065-1openalex-snapshot
Peptide-Hormone- And Serotonin-Immunoreactive Tumour Cells in Carcinoma of the Prostate
inferredcites →https://doi.org/10.1038/modpathol.2011.56openalex-snapshot
ERG–TMPRSS2 rearrangement is shared by concurrent prostatic adenocarcinoma and prostatic small cell carcinoma and absent in small cell carcinoma of the urinary bladder: evidence supporting monoclonal origin
inferredcites →https://doi.org/10.1046/j.1442-2042.2001.00347.xopenalex-snapshot
Progression of prostate cancer to neuroendocrine cell tumor
inferredcites →https://doi.org/10.1046/j.1464-4096.2001.00936.xopenalex-snapshot
Neuroendocrine differentiated small cell carcinoma presenting as recurrent prostate cancer after androgen deprivation therapy
inferredcites →https://doi.org/10.1056/nejmoa003034openalex-snapshot
Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer
inferredcites →https://doi.org/10.1097/00000478-199210000-00013openalex-snapshot
Paneth Cell-like Change and Small Cell Carcinoma of the Prostate
inferredcites →https://doi.org/10.1111/j.1442-2042.2008.02175.xopenalex-snapshot
Neuroendocrine differentiation in the progression of prostate cancer
inferredcites →https://doi.org/10.1111/j.1464-410x.2006.06041.xopenalex-snapshot
Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center
inferredcites →https://doi.org/10.1111/j.1464-410x.2011.10523.xopenalex-snapshot
Survival of patients with small cell carcinoma of the prostate during 1973–2003: a population‐based study
inferredcites →https://doi.org/10.1158/0008-5472.can-08-2229openalex-snapshot
Ionizing Radiation Induces Prostate Cancer Neuroendocrine Differentiation through Interplay of CREB and ATF2: Implications for Disease Progression
inferredcites →https://doi.org/10.1159/000020289openalex-snapshot
Low PSA Metastatic Androgen– Independent Prostate Cancer

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4127745openalex-extracted
inferred← citeshttps://doi.org/10.1007/s40487-023-00238-3openalex-snapshot
Small-Cell Carcinoma of the Prostate – Challenges of Diagnosis and Treatment: A Next of Kin and Physician Perspective Piece
inferred← citeshttps://doi.org/10.1016/j.humpath.2022.07.018openalex-snapshot
Mucinous adenocarcinoma of the prostatic urethra after brachytherapy for prostatic adenocarcinoma: a case series
inferred← citeshttps://doi.org/10.1186/s13256-020-02523-5openalex-snapshot
Small cell carcinoma of the prostate after low-dose-rate brachytherapy: a case report
inferred← citeshttps://doi.org/10.1200/jco.2013.54.3553openalex-snapshot
Neuroendocrine Prostate Cancer (NEPC) Progressing From Conventional Prostatic Adenocarcinoma: Factors Associated With Time to Development of NEPC and Survival From NEPC Diagnosis—A Systematic Review and Pooled Analysis
inferred← citeshttps://doi.org/10.3389/fonc.2014.00060openalex-snapshot
The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
inferred← citeshttps://doi.org/10.3389/fonc.2015.00037openalex-snapshot
Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine?
inferred← citeshttps://doi.org/10.3892/ijo.2013.2173openalex-snapshot
Application of a new technique, spiral tissue microarrays constructed using needle biopsy specimens, to prostate cancer research
inferred← citeshttps://doi.org/10.3892/mco.2013.69openalex-snapshot
The prognostic significance of loss of the androgen receptor and neuroendocrine differentiation in prostate biopsy specimens among castration-resistant prostate cancer patients
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.